News
ZymoGenetics loses chief medical officer | The Seattle Times
www.seattletimes.com
ZymoGenetics said today that Nicole Onetto, chief medical officer and senior vice president, will leave the Seattle biotechnology company...
OICR to spend $18.3 million on cancer research | TopNews
topnews.in
Nicole Onetto, the deputy director at OICR said that, "In many cases, we are using some drugs for the wrong patient or the wrong tumour, ...
Investegate |Basilea Pharmaceutica AG Announcements | Basilea...
www.investegate.co.uk
Investegate announcements from Basilea Pharmaceutica AG, Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
New funding pledged for targeted treatments for cancer patients - The...
www.theglobeandmail.com
New funding for three Ontario-based imaging projects aiming to bring more precision to cancer treatment
sorted by relevance / date